Rockwell Medical (RMTI) EBT Margin (2010 - 2026)

Rockwell Medical (RMTI) posted EBT Margin of 41.6% for Q1 2026, down 807.39% on a QoQ basis from 4.58% in Q4 2025, and down 3184.0% year-over-year from 1.35% in Q1 2025.

Rockwell Medical (RMTI) EBT Margin (2010 - 2026) Analysis & Trends

Rockwell Medical's EBT Margin history runs 17 years deep, the most recent figure standing at 41.6% for Q1 2026.

  • Quarterly EBT Margin fell 3184.0% year-over-year to 41.6% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 18.81% (down 1777.0% YoY) and the FY2025 annual result came in at 16.39%, up 6693.0% from the prior year.
  • EBT Margin was 41.6% for Q1 2026 at Rockwell Medical, down from 4.58% in the prior quarter.
  • Across five years, EBT Margin topped out at 5.36% in Q3 2024 and bottomed at 44.44% in Q1 2022.
  • A 5-year average of 14.19% and a median of 9.76% in 2025 frame the typical range for EBT Margin.
  • Annual changes were most pronounced in 2022 — EBT Margin soared 4905 bps — and 2026, when it slumped 3184 bps.
  • Rockwell Medical's EBT Margin stood at 12.23% in 2022, then jumped by 31 bps to 8.5% in 2023, then jumped by 63 bps to 3.16% in 2024, then slumped by 45 bps to 4.58% in 2025, then tumbled by 807 bps to 41.6% in 2026.
  • Business Quant data shows RMTI's EBT Margin at 41.6% in Q1 2026, 4.58% in Q4 2025, and 13.07% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 10.97%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 33.51%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -41.57%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 40.73%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -7.05%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 30.30%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 6.35%
10 Rockwell Medical 25.77 Mn 1.88 Mn 2.90 Mn -41.60%

Historic Data

Download Data
DateValue
Mar 31, 2026 -41.60%
Dec 31, 2025 -4.58%
Sep 30, 2025 -13.07%
Jun 30, 2025 -16.15%
Mar 31, 2025 -9.76%
Dec 31, 2024 -3.16%
Sep 30, 2024 5.36%
Jun 30, 2024 0.38%
Mar 31, 2024 -7.66%
Dec 31, 2023 -8.50%
Sep 30, 2023 -9.01%
Jun 30, 2023 -18.74%
Mar 31, 2023 -9.09%
Dec 31, 2022 -12.23%
Sep 30, 2022 -22.42%
Jun 30, 2022 -26.59%
Mar 31, 2022 -44.44%
Dec 31, 2021 -61.28%
Sep 30, 2021 -47.42%
Jun 30, 2021 -55.49%